Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

At e4m TechManch 2025, CX leaders across telecom, retail, pharma, and tech explored how AI, data, and design are redefining ...

Artificial intelligence is already helping New Yorkers with medical research, agriculture and everyday tasks. As AI advances ...

ASCO President Robin Zon, MD, FACP, FASCO, emphasizes how AI solutions and advocacy in enhancing cancer care, ensuring ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

For Stephen Yeager, who owns a Theodore company that helps lawyers with digital forensics, research and jury consulting, artificial intelligence has been a “game-changer.” But there are potential ...

Distorted self-perceptions due to body dysmorphic disorder having people seeking reassurance from ChatGPT, with dangerous ...

Although patients and the general public were identified as the primary audience, the researchers noted that AI-generated podcasts could serve as a cost-effective, scalable way for healthcare ...

Enterprises rushing to embrace generative AI face soaring costs and unclear ROI, often due to poor planning and weak cost ...

At ICML, the AI research elite gather to present papers, chase jobs, and quietly shape the future of the field.

OpenEvidence , an AI-enabled medical research aggregate platform for doctors, has scored $210 million in Series B funding, boosting the company's valuation to $3.5 billion. The round was co-led by ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...